Correlation Between NervGen Pharma and Bionomics

Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and Bionomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and Bionomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NervGen Pharma Corp and Bionomics Ltd ADR, you can compare the effects of market volatilities on NervGen Pharma and Bionomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of Bionomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and Bionomics.

Diversification Opportunities for NervGen Pharma and Bionomics

0.64

Correlation Coefficient

NervGen Pharma  Bionomics

Poor diversification

The 3 months correlation between NervGen and Bionomics is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and Bionomics Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionomics ADR and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with Bionomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionomics ADR has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and Bionomics go up and down completely randomly.

Pair Corralation between NervGen Pharma and Bionomics

Assuming the 90 days horizon NervGen Pharma is expected to generate 4.12 times less return on investment than Bionomics. But when comparing it to its historical volatility, NervGen Pharma Corp is 4.84 times less risky than Bionomics. It trades about 0.03 of its potential returns per unit of risk. Bionomics Ltd ADR is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  63.00  in Bionomics Ltd ADR on September 2, 2024 and sell it today you would lose (33.00) from holding Bionomics Ltd ADR or give up 52.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

NervGen Pharma Corp  vs.  Bionomics Ltd ADR

NervGen Pharma Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Bionomics ADR

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bionomics Ltd ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Bionomics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NervGen Pharma and Bionomics

The main advantage of trading using opposite NervGen Pharma and Bionomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, Bionomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will offset losses from the drop in Bionomics' long position.

The idea behind NervGen Pharma Corp and Bionomics Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.